FDA Inspection 700696 — Janssen Pharmaceuticals, Inc

Janssen Pharmaceuticals, Inc — FEI 2242843

The FDA completed an inspection of Janssen Pharmaceuticals, Inc on Dec 9, 2010 in Titusville, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Veterinary.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 9, 2010
Fiscal Year
2011
Product Type
Veterinary
Project Area
Bioresearch Monitoring
Location
Titusville, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
1353921 CFR 511.1(b)(4)No NCIE submitted
398321 CFR 58.105(a)Test article: characterization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.